AstraZeneca Lifts Profit Target
Stock quotes in this article:
AZN
Pfizer successfully defended a major Lipitor patent in the U.K. recently, but a Pfizer defeat in the U.S. will have a ripple effect on the entire market, Purcell says. If Pfizer loses, Crestor's U.S. market share could stall, hurting AstraZeneca's long-term EPS estimates by 5% or 6%.
Purcell doesn't own shares, but his firm plans to receive or seek investment-banking compensation from AstraZeneca in the next three months.- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
Connect with TheStreet
 |
 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,309.92 | 1,091.49 | 2,138.44 | 32.31 |
Oil *
77.12
|
|
DOWN
154.48
|
DOWN
19.14
|
DOWN
37.61
|
DOWN
0.48
|
10 Yr
3.23%
SPDR Gold
115.06
|
|
-1.48%
|
-1.72%
|
-1.73%
|
-1.46%
|
Data delayed 20 minutes |
